Europe RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Country and Growth Forecast, 2022

List of Tables

The Europe RNA Analysis Market would witness market growth of 15.1% CAGR during the forecast period (2022-2028).

Long noncoding RNAs are a prominent subclass of ncRNAs. During the extensive sequencing of cDNA libraries, lncRNAs were first identified as a functional class and first reported in mice. LncRNAs have been implicated in a wide range of molecular processes, including chromatin remodeling, transcriptional regulation, and posttranscriptional processing, albeit the bulk of these is still poorly understood.

Analysis of RNA transcripts using next-generation sequencing techniques, which need RNA to be translated into complementary DNA before sequencing, is known as RNA. It uses a variety of methods, including q PCR and microarrays. The most popular method utilized in research labs is microarray technology. It is called quantitative reverse transcription (q PCR) and is carried out using the polymerase chain reaction. Q PCR is used to identify the presence and quantity of RNA by converting it into cDNA.

The health technology sector can be led by the United Kingdom. They already have some of the most successful health technology companies in the world, which contribute to innovative innovations and improve the country's reputation abroad as a strong scientific and research base. Additionally, it has the potential to create an ecosystem that consistently generates the best transferable health-tech as well as cutting-edge approaches and insights that can enhance health outcomes.

The Germany market dominated the Europe RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,863.5 million by 2028. The UK market is experiencing a CAGR of 14.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 16% during (2022 - 2028).

Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

Kits & Reagents
Instruments
Services

By Technology

Real Time-PCR (qPCR) Technology
Sequencing Technology
Microarray Technology
Others

By End-use

Government Institutes & Academic Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)

By Application

Infectious Diseases & Pathogenesis
Epigenetics
RNA Structure & Molecular Dynamics
Development & Delivery of RNA Therapeutics
Construction of RNA Expression Atlas
Alternative RNA Splicing
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Qiagen N.V.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Eurofins Scientific Group
Merck Group
Promega Corporation

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe RNA Analysis Market, by Product
- 1.4.2 Europe RNA Analysis Market, by Technology
- 1.4.3 Europe RNA Analysis Market, by End-use
- 1.4.4 Europe RNA Analysis Market, by Application
- 1.4.5 Europe RNA Analysis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Geographical Expansions
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2022, Jun) Leading Players

Chapter 4. Europe RNA Analysis Market by Product

4.1 Europe Kits & Reagents Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Services Market by Country

Chapter 5. Europe RNA Analysis Market by Technology

5.1 Europe Real Time-PCR (qPCR) Technology Market by Country
5.2 Europe Sequencing Technology Market by Country
5.3 Europe Microarray Technology Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe RNA Analysis Market by End-use

6.1 Europe Government Institutes & Academic Centers Market by Country
6.2 Europe Hospitals & Clinics Market by Country
6.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.4 Europe Contract Research Organizations (CROs) Market by Country

Chapter 7. Europe RNA Analysis Market by Application

7.1 Europe Infectious Diseases & Pathogenesis Market by Country
7.2 Europe Epigenetics Market by Country
7.3 Europe RNA Structure & Molecular Dynamics Market by Country
7.4 Europe Development & Delivery of RNA Therapeutics Market by Country
7.5 Europe Construction of RNA Expression Atlas Market by Country
7.6 Europe Alternative RNA Splicing Market by Country
7.7 Europe Others Market by Country

Chapter 8. Europe RNA Analysis Market by Country

8.1 Germany RNA Analysis Market
- 8.1.1 Germany RNA Analysis Market by Product
- 8.1.2 Germany RNA Analysis Market by Technology
- 8.1.3 Germany RNA Analysis Market by End-use
- 8.1.4 Germany RNA Analysis Market by Application
8.2 UK RNA Analysis Market
- 8.2.1 UK RNA Analysis Market by Product
- 8.2.2 UK RNA Analysis Market by Technology
- 8.2.3 UK RNA Analysis Market by End-use
- 8.2.4 UK RNA Analysis Market by Application
8.3 France RNA Analysis Market
- 8.3.1 France RNA Analysis Market by Product
- 8.3.2 France RNA Analysis Market by Technology
- 8.3.3 France RNA Analysis Market by End-use
- 8.3.4 France RNA Analysis Market by Application
8.4 Russia RNA Analysis Market
- 8.4.1 Russia RNA Analysis Market by Product
- 8.4.2 Russia RNA Analysis Market by Technology
- 8.4.3 Russia RNA Analysis Market by End-use
- 8.4.4 Russia RNA Analysis Market by Application
8.5 Spain RNA Analysis Market
- 8.5.1 Spain RNA Analysis Market by Product
- 8.5.2 Spain RNA Analysis Market by Technology
- 8.5.3 Spain RNA Analysis Market by End-use
- 8.5.4 Spain RNA Analysis Market by Application
8.6 Italy RNA Analysis Market
- 8.6.1 Italy RNA Analysis Market by Product
- 8.6.2 Italy RNA Analysis Market by Technology
- 8.6.3 Italy RNA Analysis Market by End-use
- 8.6.4 Italy RNA Analysis Market by Application
8.7 Rest of Europe RNA Analysis Market
- 8.7.1 Rest of Europe RNA Analysis Market by Product
- 8.7.2 Rest of Europe RNA Analysis Market by Technology
- 8.7.3 Rest of Europe RNA Analysis Market by End-use
- 8.7.4 Rest of Europe RNA Analysis Market by Application

Chapter 9. Company Profiles

9.1 F. Hoffmann-La Roche Ltd.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Partnerships, Collaborations, and Agreements:
  - 9.3.5.2 Product Launches and Product Expansions:
  - 9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
  - 9.4.5.2 Product Launches and Product Expansions:
  - 9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Partnerships, Collaborations, and Agreements:
  - 9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
  - 9.6.5.2 Product Launches and Product Expansions:
  - 9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
  - 9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Recent strategies and developments:
  - 9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
  - 9.9.5.1 Partnerships, Collaborations, and Agreements:
  - 9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
  - 9.10.2.1 Product Launches and Product Expansions:
  - 9.10.2.2 Geographical Expansions:

LIST OF TABLES

TABLE 1 Europe RNA Analysis Market, 2018 - 2021, USD Million
TABLE 2 Europe RNA Analysis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- RNA Analysis Market
TABLE 4 Product Launches And Product Expansions- RNA Analysis Market
TABLE 5 Acquisition and Mergers- RNA Analysis Market
TABLE 6 Geographical Expansions - RNA Analysis Market
TABLE 7 Europe RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 8 Europe RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 9 Europe Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 16 Europe RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 17 Europe Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 26 Europe RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 27 Europe Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 36 Europe RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 37 Europe Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 49 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 50 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 51 Europe RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 52 Europe RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 53 Germany RNA Analysis Market, 2018 - 2021, USD Million
TABLE 54 Germany RNA Analysis Market, 2022 - 2028, USD Million
TABLE 55 Germany RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 56 Germany RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 57 Germany RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 58 Germany RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 59 Germany RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 60 Germany RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 61 Germany RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 62 Germany RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 63 UK RNA Analysis Market, 2018 - 2021, USD Million
TABLE 64 UK RNA Analysis Market, 2022 - 2028, USD Million
TABLE 65 UK RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 66 UK RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 67 UK RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 68 UK RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 69 UK RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 70 UK RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 71 UK RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 72 UK RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 73 France RNA Analysis Market, 2018 - 2021, USD Million
TABLE 74 France RNA Analysis Market, 2022 - 2028, USD Million
TABLE 75 France RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 76 France RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 77 France RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 78 France RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 79 France RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 80 France RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 81 France RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 82 France RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 83 Russia RNA Analysis Market, 2018 - 2021, USD Million
TABLE 84 Russia RNA Analysis Market, 2022 - 2028, USD Million
TABLE 85 Russia RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 86 Russia RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 87 Russia RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 88 Russia RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 89 Russia RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 90 Russia RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 91 Russia RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 92 Russia RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 93 Spain RNA Analysis Market, 2018 - 2021, USD Million
TABLE 94 Spain RNA Analysis Market, 2022 - 2028, USD Million
TABLE 95 Spain RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 96 Spain RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 97 Spain RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 98 Spain RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 99 Spain RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 100 Spain RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 101 Spain RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 102 Spain RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 103 Italy RNA Analysis Market, 2018 - 2021, USD Million
TABLE 104 Italy RNA Analysis Market, 2022 - 2028, USD Million
TABLE 105 Italy RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 106 Italy RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 107 Italy RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 108 Italy RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 109 Italy RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 110 Italy RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 111 Italy RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 112 Italy RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 113 Rest of Europe RNA Analysis Market, 2018 - 2021, USD Million
TABLE 114 Rest of Europe RNA Analysis Market, 2022 - 2028, USD Million
TABLE 115 Rest of Europe RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 116 Rest of Europe RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 117 Rest of Europe RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 118 Rest of Europe RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 119 Rest of Europe RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 120 Rest of Europe RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 121 Rest of Europe RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 122 Rest of Europe RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 123 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 124 Key Information - Danaher Corporation
TABLE 125 key Information - Agilent Technologies, Inc.
TABLE 126 Key Information - Thermo Fisher Scientific, Inc.
TABLE 127 Key Information - Qiagen N.V.
TABLE 128 key information - Illumina, Inc.
TABLE 129 Key Information - Bio-Rad Laboratories, Inc.
TABLE 130 Key Information - Eurofins Scientific Group
TABLE 131 key Information - Merck GrouP
TABLE 132 key Information - Promega Corporation

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche AG
FIG 6 Recent strategies and developments: Agilent Technologies, Inc.
FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.
FIG 9 Recent strategies and developments: Illumina, Inc.
FIG 10 Recent strategies and developments: Merck KGaA
FIG 11 Recent strategies and developments: Promega Corporation

Europe RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents